TrialPanorama/TrialPanorama-database huggingface dataset:
Study 39112634 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 39112634 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 39113067 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 39113190 — Predictive Biomarker (PRD): TNFRSF10A mRNA
Genes: TNFRSF10A; APO2; DR4; TRAILR1
Study 39113190 — Predictive Biomarker (PRD): TNFRSF10B mRNA
Genes: TNFRSF10B; DR5; KILLER; TRAILR2; TRICK2; ZTNFR9; UNQ160/PRO186
Study 39114670 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39114821 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 39114823 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 39114870 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39115419 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39115583 — Predictive Biomarker (PRD): DDN mRNA
Genes: DDN; KIAA0749
Study 39116013 — Predictive Biomarker (PRD): AFM mRNA
Genes: AFM; ALB2; ALBA
Study 39116153 — Pharmacodynamic Biomarker (PDY): Auditory mismatch negativity
Study 39116153 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 39116385 — Surrogate Endpoint (SUR): Blood pressure
Study 39116423 — Surrogate Endpoint (SUR): Blood pressure
Study 39116683 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39116683 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 39116683 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 39116902 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39117402 — Safety Biomarker (SAF): miR-15a
Genes: MIR15A
Study 39117445 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 39117445 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39117488 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 39117964 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 39118135 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39118150 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study 39118415 — Predictive Biomarker (PRD): PKLR mRNA
Genes: PKLR; PK1; PKL
Study 39119705 — Surrogate Endpoint (SUR): Blood pressure
Study 39120848 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39120849 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39121163 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study 39121163 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 39121163 — Safety Biomarker (SAF): Interleukin 1
Study 39121881 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 39121881 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39121992 — Surrogate Endpoint (SUR): Blood pressure
Study 39122402 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 39122403 — Predictive Biomarker (PRD): DHH mRNA
Genes: DHH
Study 39122650 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 39122717 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 39122726 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39122726 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 39123126 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study 39123210 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 39123210 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 39123434 — Safety Biomarker (SAF): Derived neutrophil to lymphocyte
Study 39123434 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 39124551 — Monitoring Biomarker (MOI): Cell-free DNA
Study 39127745 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 39127813 — Safety Biomarker (SAF): Hyaluronic acid
Study 39127924 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39128497 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39128904 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 39130048 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39130140 — Predictive Biomarker (PRD): IVL mRNA
Genes: IVL
Study 39131140 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 39131668 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study 39131784 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study 39132075 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 39133774 — Safety Biomarker (SAF): Interleukin 1
Study 39133883 — Pharmacodynamic Biomarker (PDY): Ataxin-2
Genes: ATXN2; ATX2; SCA2; TNRC13
Study 39133921 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 39133921 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 39133921 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 39133921 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 39133923 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 39134085 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 39134120 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 39134346 — Predictive Biomarker (PRD): ARHGEF5 mRNA
Genes: ARHGEF5; TIM
Study 39134391 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39134391 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 39134529 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 39134529 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 39134529 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 39134986 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 39135126 — Surrogate Endpoint (SUR): Bone mineral density
Study 39135209 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 39135452 — Predictive Biomarker (PRD): S100A8 mRNA
Genes: S100A8; CAGA; CFAG; MRP8
Study 39135452 — Predictive Biomarker (PRD): S100A12 mRNA
Genes: S100A12
Study 39135452 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study 39135452 — Predictive Biomarker (PRD): MMP2 mRNA
Genes: MMP2; CLG4A
Study 39135452 — Predictive Biomarker (PRD): CCL18 mRNA
Genes: CCL18; AMAC1; DCCK1; MIP4; PARC; SCYA18
Study 39135452 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study 39135452 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 39135452 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 39135452 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study 39135452 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 39135452 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 39135540 — Predictive Biomarker (PRD): PDXP mRNA
Genes: PDXP; CIN; PLP; PLPP
Study 39136011 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 39136011 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 39136560 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 39137044 — Pharmacodynamic Biomarker (PDY): Interleukin 7 receptor alpha
Genes: IL7R
Study 39137516 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 39137516 — Surrogate Endpoint (SUR): Serum sodium
Study 39138024 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 39138116 — Predictive Biomarker (PRD): PGM1 mRNA
Genes: PGM1
Study 39138518 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39138518 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 39138591 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study 39138591 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 39138826 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-122
Genes: MIR122
Study 39138826 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-21
Genes: MIR21
Study 39138849 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 39139188 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 39139216 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 39139218 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39139218 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39139270 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 39140267 — Predictive Biomarker (PRD): FER mRNA
Genes: FER; TYK3
Study 39140490 — Predictive Biomarker (PRD): OCA2 mRNA
Genes: OCA2; D15S12; P
Study 39140573 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 39140777 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 39140975 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 39141378 — Surrogate Endpoint (SUR): Serum uric acid
Study 39141577 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 39141853 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 39142718 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 39142718 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study 39142723 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 39142727 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 39145700 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study 39145700 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 39145962 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 39145961 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study 39146624 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 39146670 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study 39146670 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 39147364 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 39147695 — Surrogate Endpoint (SUR): Serum creatinine
Study 39147695 — Monitoring Biomarker (MOI): Cell-free DNA
Study 39148031 — Safety Biomarker (SAF): Prognostic nutrition index
Study 39148102 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study 39148107 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 39148430 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study 39148905 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 39149468 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study 39149474 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 39149474 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 39149474 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 39149474 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 39149474 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 39149474 — Monitoring Biomarker (MOI): Cell-free DNA
Study 39149645 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study 39150490 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study 39150490 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 39150859 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 39151033 — Surrogate Endpoint (SUR): Serum calcium
Study 39151419 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 39151420 — Safety Biomarker (SAF): UGT1A1
Genes: UGT1A
Study 39151756 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 39151920 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 39151920 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39151920 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 39151920 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 39152361 — Predictive Biomarker (PRD): BGN mRNA
Genes: BGN; SLRR1A
Study 39153127 — Predictive Biomarker (PRD): NOTCH1 mRNA
Genes: NOTCH1; TAN1
Study 39153127 — Predictive Biomarker (PRD): Hormone receptor
Study 39153817 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study 39153977 — Surrogate Endpoint (SUR): Blood pressure
Study 39154299 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 39154299 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 39154316 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 39154808 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 39155155 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study 39155847 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 39158569 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 39158584 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 39158832 — Surrogate Endpoint (SUR): Serum calcium
Study 39158946 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 39158946 — Surrogate Endpoint (SUR): Serum creatinine
Study 39159183 — Surrogate Endpoint (SUR): Blood pressure
Study 39159269 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39159398 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39159418 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39159418 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 39159418 — Predictive Biomarker (PRD): Hormone receptor
Study 39159624 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 39159624 — Surrogate Endpoint (SUR): Serum potassium
Study 39159997 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 39160468 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39160668 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study 39161870 — Surrogate Endpoint (SUR): Blood pressure
Study 39161962 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 39161962 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 39162872 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39163362 — Monitoring Biomarker (MOI): Procalcitonin
Study 39163362 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39163371 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 39163505 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 39163858 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 39163971 — Surrogate Endpoint (SUR): Blood pressure
Study 39163972 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39164167 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 39164518 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 39164518 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 39164518 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study 39164518 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 39164557 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 39164613 — Predictive Biomarker (PRD): LSS mRNA
Genes: LSS; OSC
Study 39164673 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study 39164933 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 39165278 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 39165373 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 39165498 — Monitoring Biomarker (MOI): Cell-free DNA
Study 39166323 — Surrogate Endpoint (SUR): Blood pressure
Study 39166791 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study 39166791 — Predictive Biomarker (PRD): TMEM97 mRNA
Genes: TMEM97; MAC30; S2R
Study 39167348 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 39167366 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study 39167766 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 39168180 — Predictive Biomarker (PRD): CEACAM6 mRNA
Genes: CEACAM6; NCA
Study 39168180 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 39168901 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 39168901 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 39168901 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 39168946 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 39168966 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 39168966 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 39168966 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 39169033 — Predictive Biomarker (PRD): Hormone receptor
Study 39169353 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39169353 — Surrogate Endpoint (SUR): Blood pressure
Study 39169663 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 39169827 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study 39169827 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 39170271 — Safety Biomarker (SAF): Hyaluronic acid
Study 39171125 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 39171416 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 39171639 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 39171639 — Surrogate Endpoint (SUR): Serum creatinine
Study 39171639 — Surrogate Endpoint (SUR): Blood pressure
Study 39171864 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 39171906 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 39171906 — Surrogate Endpoint (SUR): Blood pressure
Study 39172356 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 39172479 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 39172627 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 39172730 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 39172743 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study 39172743 — Predictive Biomarker (PRD): RHCE mRNA
Genes: RHCE; RHC; RHE
Study 39172760 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 39173098 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 39173603 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 39173603 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 39173703 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 39174542 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 39174542 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 39174547 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 39174547 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39174547 — Predictive Biomarker (PRD): Hormone receptor
Study 39175480 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 39176240 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 39176240 — Surrogate Endpoint (SUR): Blood pressure
Study 39177931 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 39177931 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 39178048 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 39178291 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39178369 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 39179206 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39179206 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 39179252 — Surrogate Endpoint (SUR): Blood pressure
Study 39179255 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39179255 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 39179255 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 39179257 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39179638 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 39179638 — Surrogate Endpoint (SUR): Blood pressure
Study 39179700 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 39179863 — Surrogate Endpoint (SUR): Pathological complete response
Study 39179948 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study 39179982 — Surrogate Endpoint (SUR): Blood pressure
Study 39180809 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD